Viewing Study NCT07032532


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-29 @ 11:04 PM
Study NCT ID: NCT07032532
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-26
First Post: 2025-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module